The Prone to Supine Breast MRI Trial
Principal Investigator (?)
Study Number
D17168
Summary
The purpose of this study is to determine whether a supine MRI obtained immediately after a
standard diagnostic prone MRI exam, without a second injection of gadolinium (Gd) contrast
material, would be of sufficient quality to allow the Radiologist to define the tumor edges
("segment" the tumor) so that a 3-D image of the tumor can be generated to form a BCL.
Phase (?)
Phase III
Sponsor (?)
NCCC
Available at the following location(s)
Lebanon
Contact Information
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
- Cancer Help Line: (800) 639-6918
- Email: cancer.research.nurse@dartmouth.edu
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.